Apr 23, 2020 Roth Capital Partners Acts as Co-Manager for Crinetics Pharmaceuticals (Nasdaq: CRNX) in its $115.1 Million Follow-On Roth Capital Partners
Apr 20, 2020 Roth Capital Partners Acts as Lead Manager for Bionano Genomics (NASDAQ: BNGO) in its $18 Million Follow-On Roth Capital Partners
Apr 16, 2020 Roth Capital Partners acts as Financial Advisor to Boardriders on its sale of Xcel to ZG Holdings Roth Capital Partners
Mar 4, 2020 Roth Capital Partners Announces the Addition of George Kelly and Matthew Koranda to its Consumer Research Group Business Wire
Mar 2, 2020 Roth Capital Partners Acts as Sole Placement Agent for Lipocine Inc. (NASDAQ:LPCN) in its $6 Million Registered Direct Roth Capital Partners
Feb 19, 2020 Roth Capital Partners advises NV5 on its Acquisition of Quantum Spatial Roth Capital Partners
Feb 18, 2020 Roth Capital Partners Acts as Co-Manager for Applied Genetic Technologies Corporation (Nasdaq: AGTC) in its $37.4 Million Follow-On Roth Capital Partners
Feb 14, 2020 Roth Capital Partnersacts as Sole Book-Running Manager for Myomo, Inc. (NYSE American: MYO) in its $15 Million Follow-On Roth Capital Partners